Skip to main content

22-431 Offer Patients Added Treatment Options for COVID-19 with Oral Antivirals

June 10, 2022

This information applies to Physicians and Independent Practice Associations.

PaxlovidTM and LagevrioTM – authorized for emergency use by the U.S. Food and Drug Administration – can be prescribed to treat mild to moderate COVID-19 for use at home.

This flyer shares information about two COVID-19 oral antiviral medications – PaxlovidTM and LagevrioTM. These are available by prescription only to individuals who qualify, have mild to moderate COVID-19 symptoms and who are at high risk.

Download the provider updateThis PDF document will open in a new window.

Contact Us icon

Need help? We're here for you.

Contact Us
Y0020_WCM_178064E_M Last Updated On: 11/10/2025
Due to the current government shutdown, we want to let you know that updates to your Medicare account may take longer than usual. Learn more about how this may affect your services. ×